Skip to main content
All lobbying firms

W STRATEGIES, LLC

Registrant on federal lobbying filings · filed 2025 to 2026

$5,590,000 Income reported
26 Clients represented
131 Filings counted
0 Former members lobbying

Income is the fees this registrant reported being paid to lobby. 1 filing on this record was restated by a later amendment and is left out of every total here. Everything on this page is grouped by the registrant's LDA id (400605842), not by name.

 Clients 26
 Lobbyists named 1
  • DARREN WILLCOX 39 filings · through 2026 Asst. for Policy, Speaker Dennis Hastert; Admin. Asst., Legislative Director, Legislative Asst., Cong. Porter Goss; House Rules Comm. Assoc., Subcommittee Staf…

A lobbyist who previously held a covered government position must disclose it. We flag the ones whose name resolves to a member of Congress and link the ones still in our roster. The revolving door collects them across every firm.

 Reported by year 2 years
  • 2026 $1,900,000 46 filings
  • 2025 $3,690,000 85 filings
 Issues lobbied 6

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 6
  • HOUSE OF REPRESENTATIVES 110
  • SENATE 33
  • Centers For Medicare and Medicaid Services (CMS) 6
  • Agriculture, Dept of (USDA) 1
  • Health & Human Services, Dept of (HHS) 1
  • Office of Management & Budget (OMB) 1
 Recent filings 132 total
RR
KAILERA THERAPEUTICS INC.
3rd Quarter (July 1 - Sep 30) 2026 · posted Sep 16, 2026
View →
Q2
UNITED SERVICES AUTOMOBILE ASSOCIATION (USAA)
2nd Quarter (Apr 1 - June 30) 2026 · $30,000 income · posted Jul 20, 2026
View →
Q2
SANOFI U.S. SERVICES, INC.
2nd Quarter (Apr 1 - June 30) 2026 · House · $50,000 income · posted Jul 20, 2026
View →
Q2
PHLOW CORP.
2nd Quarter (Apr 1 - June 30) 2026 · House · $50,000 income · posted Jul 20, 2026
View →
Q2
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2nd Quarter (Apr 1 - June 30) 2026 · House · $60,000 income · posted Jul 20, 2026
View →
Q2
PAPERBIRCH STRATEGIES ON BEHALF OF AP3 BIOMEDICAL
2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $40,000 income · posted Jul 20, 2026
View →
Q2
OTSUKA AMERICA PHARMACEUTICAL, INC.
2nd Quarter (Apr 1 - June 30) 2026 · House · $50,000 income · posted Jul 20, 2026
View →
Q2
MERCK & CO., INC.
2nd Quarter (Apr 1 - June 30) 2026 · House · $50,000 income · posted Jul 20, 2026
View →
Q2
MEDTRONIC, INC.
2nd Quarter (Apr 1 - June 30) 2026 · House · $40,000 income · posted Jul 20, 2026
View →
Q2
JUUL LABS INC
2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $60,000 income · posted Jul 20, 2026
View →
Q2
IPSEN BIOPHARMACEUTICALS, INC.
2nd Quarter (Apr 1 - June 30) 2026 · $20,000 income · posted Jul 20, 2026
View →
Q2
INCYTE CORPORATION
2nd Quarter (Apr 1 - June 30) 2026 · House · $60,000 income · posted Jul 20, 2026
View →
Q2
GLAXOSMITHKLINE
2nd Quarter (Apr 1 - June 30) 2026 · House · $40,000 income · posted Jul 20, 2026
View →
Q2
GILEAD SCIENCES, INC.
2nd Quarter (Apr 1 - June 30) 2026 · House · $60,000 income · posted Jul 20, 2026
View →
Q2
EXELIXIS, INC.
2nd Quarter (Apr 1 - June 30) 2026 · $60,000 income · posted Jul 20, 2026
View →
Q2
DYNE THERAPEUTICS, INC.
2nd Quarter (Apr 1 - June 30) 2026 · House · $40,000 income · posted Jul 20, 2026
View →
Q2
DELFI DIAGNOSTICS
2nd Quarter (Apr 1 - June 30) 2026 · House · $30,000 income · posted Jul 20, 2026
View →
Q2
CALIFORNIA LIFE SCIENCES
2nd Quarter (Apr 1 - June 30) 2026 · House · $40,000 income · posted Jul 20, 2026
View →
Q2
BRISTOL-MYERS SQUIBB COMPANY
2nd Quarter (Apr 1 - June 30) 2026 · House · $50,000 income · posted Jul 20, 2026
View →
Q2
ASTRAZENECA PHARMACEUTICALS LP
2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $80,000 income · posted Jul 20, 2026
View →

Showing the 20 most recent of 132 filings. Search the explorer for "W STRATEGIES, LLC".

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem